What Happened? Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped 2.3% in the morning session after JPMorgan ...

JP Morgan recently initiated coverage on Exponent with an Overweight/Buy rating, highlighting the firm’s position as a ...

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

Exponent (EXPO) recently reported third quarter earnings and revenue that came in ahead of expectations, a result that coincided with analyst upgrades and a more upbeat tone from management regarding ...

Prosper Stars & Stripes, a long/short equity fund, recently released its second quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund underperformed and generated a net ...

Earnings from consulting firm Exponent (NASDAQ: EXPO) came in below expectations, and the company continues to see challenges heading into 2024. Investors are moving to the sidelines, sending shares ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. A general sense of optimism was ...

Engineering and scientific consulting firm Exponent Inc (NASDAQ:EXPO) shares are skyrocketing after the company reported better-than-expected first-quarter FY24 earnings. Exponent reported ...

Good day and welcome to the Exponent, Inc. First Quarter 2025 Earnings Conference Call. All participants will be in the listen-only mode. [Operator Instructions] Please note, this event is being ...

The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Exponent (EXPO) been one of those stocks this year?